SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Response Biomedical (V.RBM)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Dick Martin12/1/2005 3:28:02 PM
  Read Replies (1) of 655
 
LXU Healthcare, Inc to distribute cardiac tests; another piece falls into place; this company continues to fullfill its mission, we probably won't see results on the bottom line until next year but when it comes together I think we be doing good.

Regards
Dick

Response Biomedical Corp. (TSX–V: RBM, OTCBB: RPBIF), announced today that it has appointed LXU Healthcare, Inc., a leading provider of premier medical equipment and specialty devices, as its exclusive distributor for the RAMP Cardiovascular Tests in a number of key markets in the USA

Response Biomedical has received US Food and Drug Administration (FDA) and Canadian regulatory clearance for its fluorescence–based RAMP Reader for general clinical use and three RAMP Cardiac Marker Tests for detecting troponin I, CK–MB and myoglobin. LXU Medical, LXU Healthcare’s Medical–Surgical division will also distribute the Company’s NT–proBNP test which is expected to be available towards the end of 2006. These rapid quantitative tests assist in the rapid diagnosis of a broad array of cardiovascular conditions including congestive heart failure, heart attack or acute myocardial infarction (AMI), and risk stratification of patients with acute coronary syndrome or heart failure

responsebio.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext